Skip to main content
Clinical Trials/NCT05819294
NCT05819294Active, not recruitingNot Applicable

A Feasibility Study of the Diagnostic Yield of Pre-aspiration Pleural Fluid Agitation in Non-infected Pleural Effusion

Alexandria University1 site in 1 country55 target enrollmentStarted: April 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
55
Locations
1
Primary Endpoint
Diagnostic yield of the cytological analysis

Study Overview

Brief Summary

The goal of this study is to compare the diagnostic yield in terms of cellular content and biochemical characteristics of pre-aspiration agitated pleural fluid versus that of conventionally aspirated fluid in pleural infection patients. The hypothesis is that the agitated fluid would be more representative and thus may aid the diagnosis of non-infected exudative pleural effusions.

Detailed Description

Transudation or exudation are the two mechanisms by which fluid accumulates, where Starling forces' imbalance is responsible for the former and inflammatory increase in capillary permeability accounts for the latter. Despite the history and presentation commonly suggesting the underlying etiology, pleural fluid aspiration and analysis is frequently required for confirmation of the nature and cause of the effusion. Aspirated pleural fluid is routinely subjected to biochemical analysis as well as microbiological and cytological analysis especially when infection or neoplasia is suspected. One drawback however to thoracentesis analysis is the relatively low diagnostic yield in different forms of exudative effusion. Tuberculous pleural effusions have a yield of <10% on acid-fast bacilli smears and overall yield <30% on solid culture. Conventional cytologic analysis from malignant pleural effusions also show a relatively low overall yield of around 51%, though this could be highly variable depending on the primary cancer involved (6% in mesothelioma - 80% in ovarian adenocarcinoma).In addition, it is not uncommon for analysis results to widely vary in the same patient in those with loculated and in malignant pleural effusions. This could be attributed to the compartmentalization in complex septated collections and heterogenous distribution of cellular components throughout the pleural space. The gold standard however in diagnosing unexplained exudative pleural effusions is pleural biopsy which is technically demanding and sometimes associated with longer hospital stay along with the increased incurred costs.

The investigators propose a method for improving the representativeness of pleural fluid samples via pleural agitation prior to aspiration in exudative noninfected pleural effusion. The aim is to test the feasibility and safety of using pleural fluid agitation prior to aspiration and to investigate the potential for an improved diagnostic yield using this novel thoracentesis technique in patients with exudative non-infected pleural effusion. A control group of 10 participants with transudative pleural effusion (based on history, clinical picture, and imaging) will be included to exclude any effect of the agitation procedure on the biochemical profile of the pleural fluid. These will include patients with uncontrolled heart failure, renal or hepatic impairment presenting with classical uncomplicated free pleural effusion.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Masking Description

Laboratory personnel responsible for the cytological and biochemical analysis will be blinded to the identity of the paired samples

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > 18 years old
  • At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound)

Exclusion Criteria

  • Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation
  • Hemodynamic instability
  • Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose < 40 mg/dL or pH <7.2 with lower respiratory infection, positive gram stain or bacterial culture or pus on aspiration

Outcomes

Primary Outcomes

Diagnostic yield of the cytological analysis

Time Frame: 14 days

Percentage of samples with a positive cytological result among both aspiration techniques

Diagnostic yield of the microbiolocal analysis (mycobacterial / fungal)

Time Frame: 14 days

Percentage of samples with a evidence of mycobacterial / fungal elements among both aspiration techniques

Incidence of adverse events with pre-aspiration fluid agitation

Time Frame: 14 days

Percentage of patients with incidence of adverse events during or right after pre-aspiration fluid agitation including pneumothorax or significant pain or cough or oxygen desaturation

Secondary Outcomes

  • Glusose level difference between both aspiration method(results within 1 day of sampling)
  • Protein level difference between both aspiration method(results within 1 day of sampling)
  • Lactate dehydrogenase (LDH) level difference between both aspiration method(results within 1 day of sampling)
  • Lymphocytic count difference between both aspiration method(results within 1 day of sampling)
  • Neutrophilic count difference between both aspiration method(results within 1 day of sampling)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Salama Sadaka

Lecturer

Alexandria University

Study Sites (1)

Loading locations...

Similar Trials

Diagnostic Yield of Agitated Exudative... | Clinical Trial